Endometrial cancer: open trials in Belgium

23 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT07902375
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Trial Treatment · Universiteit Antwerpen
University Hospital of Antwerp (UZA), Edegem
Registry updated 2026-11-06
NCT05856981
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Sairopa B.V.
Grand Hopital de Charleroi (GHdC) - Hopital Notre Dame, Charleroi
Registry updated 2026-11-03
NCT07166094
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Trial Treatment · Phase 3 · Genmab
Saint-Luc University Clinics, Brussels · Antwerp University Hospital, Edegem · Grand Hôpital de Charleroi, Gilly · Universitair Ziekenhuis Leuven, Leuven · CHU UCL Namur/Ste Elisabeth, Namur · Vitaz, Sint-Niklaas
Registry updated 2026-11-03
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Centre Hospitalier Universitaire Brugmann - Victor Horta, Brussels
Registry updated 2026-10-30
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Cliniques universitaires Saint-Luc, Brussels · UZA, Edegem · Universitair Ziekenhuis Gent, Ghent · Universitair Ziekenhuis Brussel, Jette · UZ Leuven, Leuven
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Grand Hopital de Charleroi, Charleroi · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-26
NCT06340568
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Trial Treatment · Phase 3 · BioNTech SE
Institut Jules Bordet, Anderlecht · Grand Hopital de Charleroi, Charleroi · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · Az Maria Middelares Gent, Gent · Algemeen Ziekenhuis Groeninge, Kortrijk · UZ Leuven, Leuven · CHC MontLégia, Liège · Centre Hospitalier Universitaire de Liège, Liège · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-16
NCT05123482
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Anderlecht · Leuven
Registry updated 2026-10-13
NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
CHU Saint-Pierre, Brussels · Grand Hopital de Charleroi, Charleroi · Az Maria Middelares Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège
Registry updated 2026-10-13
NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Trial Treatment · Phase 3 · AstraZeneca
Institut Jules Bordet, Anderlecht · Az Maria Middelares Gent, Gent · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-13
NCT06276491
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Xencor, Inc.
AZ Groeninge, Kortrijk · UZ Leuven, Leuven · CHU de Liège, Liège
Registry updated 2026-10-09
NCT05255653
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Trial Treatment · Phase 3 · Leiden University Medical Center
Institut Jules Bordet, Anderlecht · Grand Hopital de Charleroi, Charleroi · Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHU de Liège, Liège · CHU Helora, Mons · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur · Algemeen Ziekenhuis Damiaan Oostende, Ostend · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Vitaz, Sint-Niklaas · AZ Turnhout, Turnhout
Registry updated 2026-10-08
2025-524160-38-00
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
UZ Leuven, Leuven
Registry updated 2026-10-01
NCT03564340
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Antwerp University Hospital, Edegem · Grand Hopital De Charleroi, Gerpinnes · UZ Leuven, Leuven
Registry updated 2026-09-25
NCT04590326
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
UZ Leuven, Leuven
Registry updated 2026-09-24
NCT07306559
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Trial Treatment · Phase 1 · Boehringer Ingelheim
Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-08-21
2024-519818-31-01
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )
Trial Treatment · Phase 3 · Genmab A/S
Grand Hopital de Charleroi, Charleroi · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · JESSA Ziekenhuis, Hasselt · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Vitaz, Sint-Niklaas
Registry updated 2026-08-10
NCT07044336
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Trial Treatment · Phase 3 · AstraZeneca
Institut Jules Bordet, Anderlecht · Grand Hopital de Charleroi, Charleroi · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · Az Maria Middelares Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · CHC MontLégia, Liège · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-07-29
NCT05208762
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Institut Jules Bordet, Anderlecht
Registry updated 2026-07-22
NCT06906341
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Trial Treatment · Phase 2 · Corcept Therapeutics
328, Aalst · 326, Charleroi · 325, Hasselt · 108, Leuven
Registry updated 2026-07-16
NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Eli Lilly and Company
Institut Jules Bordet, Anderlecht · UZ Leuven, Leuven
Registry updated 2026-07-07
NCT05642780
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Trial Treatment · Phase 2 · Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
AZ KLINA, Brasschaat · Grand Hopital de Charleroi, Charleroi · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-05-19
NCT06354738
Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment
Trial Treatment · University Hospital, Gasthuisberg
UZ Gasthuisberg, Katholieke Universiteit Leuven, Leuven
Registry updated 2024-04-17

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error